K952309

Substantially Equivalent

N LATEX IGA

Applicant: Behring Diagnostics, Inc.
Product code: CZP
Advisory panel: Immunology
Date received: 1995-05-17
Decision date: 1995-06-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westwood, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.